Genistein Improves Barrier Function and Proliferation of Human Umbilical Vein Endothelial Cells from Preeclampsia Patients

Dan Wu; Lixing Liu; Min Zhang; Xianhui Min

doi:doi:10.11648/j.cmr.20221102.13

| Peer-Reviewed

Genistein Improves Barrier Function and Proliferation of Human Umbilical Vein Endothelial Cells from Preeclampsia Patients

Dan Wu, Lixing Liu, Min Zhang, Xianhui Min

Published in Clinical Medicine Research (Volume 11, Issue 2)

Received: 4 March 2022 Accepted: 21 March 2022 Published: 14 April 2022

Views: Downloads:

Download PDF

Share This Article

Twitter
Linked In
Facebook

Abstract

Preeclampsia (PE), which is characterized by hypertension in women who have normal blood pressure before pregnancy and is accompanied by proteinuria, edema, and major organ damage, is the major cause of the increased mortality in pregnant women and perinatal fetuses. So far, genistein is recognized as the only safe and effective natural phytoestrogen without estrogen-like adverse reactions. Recent studies show that genistein may play a significant role in controlling oxidative/nitrative stress during preeclampsia, indicating a possible beneficial role of genistein in the prevention of preeclampsia. However, the ability of genistein to prevent and treat pregnancy-induced hypertension, especially preeclampsia, is unknown. To study the effect of genistein on endothelial cell damage in preeclampsia, we isolated human umbilical vein cells (HUVEC) from 20 normal pregnant women and 40 preeclampsia patients (half treated with genistein and the other half untreated). We found that HUVEC barrier function, proliferation, nitric oxide synthesis, glutathione peroxidase activity, and Bcl-2 expression were significantly decreased in the PE group. Furthermore, 8-hydroxy-2’-deoxyguanosine levels and Bax expression were significantly increased comparing to control group. Genistein treatment reversed these changes in the PE group, suggesting that genistein reduces endothelial cell damage in preeclampsia HUVEC and providing a supporting the use of genistein for PE prevention and treatment.

Published in	Clinical Medicine Research (Volume 11, Issue 2)
DOI	10.11648/j.cmr.20221102.13
Page(s)	28-35
Creative Commons	This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright	Copyright © The Author(s), 2022. Published by Science Publishing Group

Keywords

Genistein, Preeclampsia, Human Umbilical Vein Endothelial Cells, Oxidative Stress, Anti-apoptosis

References

[1]	Martin Jr JN and Morris RF. Preeclampsia-Spectrum Hypertensive Disorders of Pregnancy: Gestational Hypertension, Preeclampsia, Eclampsia, Chronic Hypertension, and HELLP Syndrome. In: editors. Sex Differences in Cardiovascular Physiology and Pathophysiology. Elsevier; 2019. p. 121-136.
[2]	Jie L. Beijing: People's Publishing House, 2008.
[3]	Yang Q and Ding Y. The relationship between MMP-1, PAR-1 and their roles in vascular endothelial injury in preeclampsia. J Inner Mongolia Med Univ 2016; 38: 143-146.
[4]	Zhang M and Wang X. The role of endothelial progenitor cells in pre-eclampsia. J Int Obstet Gynecol 2017; 44: 614-617.
[5]	Si H and Liu D. Phytochemical genistein in the regulation of vascular function: new insights. Curr Med Chem 2007; 14: 2581-2589.
[6]	Irace C, Marini H, Bitto A, Altavilla D, Polito F, Adamo EB, Arcoraci V, Minutoli L, Di Benedetto A, Di Vieste G, de Gregorio C, Gnasso A, Corrao S, Licata G and Squadrito F. Genistein and endothelial function in postmenopausal women with metabolic syndrome. Eur J Clin Invest 2013; 43: 1025-1031.
[7]	Poston L. Endothelial dysfunction in pre-eclampsia. Pharmacol Rep 2006; 58 Suppl: 69-74.
[8]	Bdolah Y, Karumanchi SA and Sachs BP. Recent advances in understanding of preeclampsia. Croat Med J 2005; 46: 728-736.
[9]	Baker AM, Klein RL, Moss KL, Haeri S and Boggess K. Maternal serum dyslipidemia occurs early in pregnancy in women with mild but not severe preeclampsia. Am J Obstet Gynecol 2009; 201: 293 e291-294.
[10]	Liu L, Zhang M, Li L, Li C, Min X and Zheng M. Expression and clinical significance of ATP-binding cassette transporter 1 in serum and placental tissue in Chinese patients with preeclampsia. Gynecol Obstet Invest 2014; 78: 194-200.
[11]	Blum A, Shenhav M, Baruch R and Hoffman M. Endothelial dysfunction in preeclampsia and eclampsia: current etiology and future non-invasive assessment. Isr Med Assoc J 2003; 5: 724-726.
[12]	Perkin AG and Newbury FG. LXXIX.—The colouring matters contained in dyer's broom (Genista tinctoria) and heather (Calluna vulgaris). Journal of the Chemical Society, Transactions 1899; 75: 830-839.
[13]	Tumova L and Tuma J. The effect of UV light on isoflavonoid production in G enista tinctoria culture in vitro. Acta Physiologiae Plantarum 2011; 33: 635-640.
[14]	Szkudelska K and Nogowski L. Genistein--a dietary compound inducing hormonal and metabolic changes. J Steroid Biochem Mol Biol 2007; 105: 37-45.
[15]	Donghua L and Honglin H. Journal of Clinical and Pathology 2015; 8: 1551-1558.
[16]	Kaiying L, Yuanying H and Jinzhen C. Food Safety Guide 2016; 12: 86-88.
[17]	Zhao C, Meng F, Geng L, Zhao X, Zhou H, Zhang Y and Qin S. Cardiac-protective effects and the possible mechanisms of alatamine during acute myocardial ischemia. Can J Physiol Pharmacol 2016; 94: 433-440.
[18]	Fernandez AR, Omar SZ and Husain R. Role of Genistein in Preeclampsia: A Case-Control Study. 2016; 61: 47.
[19]	Ekambaram P, Balan C and Susai CJM. Genistein attenuates oxidative damage in preeclamptic placental trophoblast. Hypertension in Pregnancy 1-14.
[20]	Pan Y, Wang N, Xia P, Wang E, Guo Q and Ye Z. Inhibition of Rac1 ameliorates neuronal oxidative stress damage via reducing Bcl-2/Rac1 complex formation in mitochondria through PI3K/Akt/mTOR pathway. Experimental neurology 2018; 300: 149-166.
[21]	Susnow N, Zeng L, Margineantu D and Hockenbery DM. Bcl-2 family proteins as regulators of oxidative stress. Semin Cancer Biol 2009; 19: 42-49.
[22]	Vijayalakshhmi B, Sesikeran B, Udaykumar P, Kalyanasundaram S and Raghunath M. Effects of vitamin restriction and supplementation on rat intestinal epithelial cell apoptosis. Free Radic Biol Med 2005; 38: 1614-1624.
[23]	He L, Feng J, Xiao R, Yu H, Ma W, Ding B and Yuan L. Effect of genistein on β-amyloid peptide 25-35 mediated apoptosis-related gene expression in PC12 cells. Chinese Journal of Food Hygiene 2011; 23: 100-105.
[24]	Maged AM, Aid G, Bassiouny N, Eldin DS, Dahab S and Ghamry NK. Association of biochemical markers with the severity of pre-eclampsia. Int J Gynaecol Obstet 2017; 136: 138-144.
[25]	Henderson JT, Thompson JH, Burda BU and Cantor A. Preeclampsia Screening: Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA 2017; 317: 1668-1683.
[26]	Khera A, Vanderlelie JJ, Holland O and Perkins AV. Overexpression of Endogenous Anti-Oxidants with Selenium Supplementation Protects Trophoblast Cells from Reactive Oxygen Species-Induced Apoptosis in a Bcl-2-Dependent Manner. Biological Trace Element Research 2016; 177: 1-10.

Cite This Article

Plain Text BibTeX RIS

APA Style

Dan Wu, Lixing Liu, Min Zhang, Xianhui Min. (2022). Genistein Improves Barrier Function and Proliferation of Human Umbilical Vein Endothelial Cells from Preeclampsia Patients. Clinical Medicine Research, 11(2), 28-35. https://doi.org/10.11648/j.cmr.20221102.13

Copy | Download

ACS Style

Dan Wu; Lixing Liu; Min Zhang; Xianhui Min. Genistein Improves Barrier Function and Proliferation of Human Umbilical Vein Endothelial Cells from Preeclampsia Patients. Clin. Med. Res. 2022, 11(2), 28-35. doi: 10.11648/j.cmr.20221102.13

Copy | Download

AMA Style

Dan Wu, Lixing Liu, Min Zhang, Xianhui Min. Genistein Improves Barrier Function and Proliferation of Human Umbilical Vein Endothelial Cells from Preeclampsia Patients. Clin Med Res. 2022;11(2):28-35. doi: 10.11648/j.cmr.20221102.13

Copy | Download

@article{10.11648/j.cmr.20221102.13,
  author = {Dan Wu and Lixing Liu and Min Zhang and Xianhui Min},
  title = {Genistein Improves Barrier Function and Proliferation of Human Umbilical Vein Endothelial Cells from Preeclampsia Patients},
  journal = {Clinical Medicine Research},
  volume = {11},
  number = {2},
  pages = {28-35},
  doi = {10.11648/j.cmr.20221102.13},
  url = {https://doi.org/10.11648/j.cmr.20221102.13},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.cmr.20221102.13},
  abstract = {Preeclampsia (PE), which is characterized by hypertension in women who have normal blood pressure before pregnancy and is accompanied by proteinuria, edema, and major organ damage, is the major cause of the increased mortality in pregnant women and perinatal fetuses. So far, genistein is recognized as the only safe and effective natural phytoestrogen without estrogen-like adverse reactions. Recent studies show that genistein may play a significant role in controlling oxidative/nitrative stress during preeclampsia, indicating a possible beneficial role of genistein in the prevention of preeclampsia. However, the ability of genistein to prevent and treat pregnancy-induced hypertension, especially preeclampsia, is unknown. To study the effect of genistein on endothelial cell damage in preeclampsia, we isolated human umbilical vein cells (HUVEC) from 20 normal pregnant women and 40 preeclampsia patients (half treated with genistein and the other half untreated). We found that HUVEC barrier function, proliferation, nitric oxide synthesis, glutathione peroxidase activity, and Bcl-2 expression were significantly decreased in the PE group. Furthermore, 8-hydroxy-2’-deoxyguanosine levels and Bax expression were significantly increased comparing to control group. Genistein treatment reversed these changes in the PE group, suggesting that genistein reduces endothelial cell damage in preeclampsia HUVEC and providing a supporting the use of genistein for PE prevention and treatment.},
 year = {2022}
}

Copy | Download

TY  - JOUR
T1  - Genistein Improves Barrier Function and Proliferation of Human Umbilical Vein Endothelial Cells from Preeclampsia Patients
AU  - Dan Wu
AU  - Lixing Liu
AU  - Min Zhang
AU  - Xianhui Min
Y1  - 2022/04/14
PY  - 2022
N1  - https://doi.org/10.11648/j.cmr.20221102.13
DO  - 10.11648/j.cmr.20221102.13
T2  - Clinical Medicine Research
JF  - Clinical Medicine Research
JO  - Clinical Medicine Research
SP  - 28
EP  - 35
PB  - Science Publishing Group
SN  - 2326-9057
UR  - https://doi.org/10.11648/j.cmr.20221102.13
AB  - Preeclampsia (PE), which is characterized by hypertension in women who have normal blood pressure before pregnancy and is accompanied by proteinuria, edema, and major organ damage, is the major cause of the increased mortality in pregnant women and perinatal fetuses. So far, genistein is recognized as the only safe and effective natural phytoestrogen without estrogen-like adverse reactions. Recent studies show that genistein may play a significant role in controlling oxidative/nitrative stress during preeclampsia, indicating a possible beneficial role of genistein in the prevention of preeclampsia. However, the ability of genistein to prevent and treat pregnancy-induced hypertension, especially preeclampsia, is unknown. To study the effect of genistein on endothelial cell damage in preeclampsia, we isolated human umbilical vein cells (HUVEC) from 20 normal pregnant women and 40 preeclampsia patients (half treated with genistein and the other half untreated). We found that HUVEC barrier function, proliferation, nitric oxide synthesis, glutathione peroxidase activity, and Bcl-2 expression were significantly decreased in the PE group. Furthermore, 8-hydroxy-2’-deoxyguanosine levels and Bax expression were significantly increased comparing to control group. Genistein treatment reversed these changes in the PE group, suggesting that genistein reduces endothelial cell damage in preeclampsia HUVEC and providing a supporting the use of genistein for PE prevention and treatment.
VL  - 11
IS  - 2
ER  -

Copy | Download

Author Information

Dan Wu

Department of Obstetrics and Gynecology, Putian University, Putian, China
Lixing Liu

Department of Obstetrics and Gynecology, Putian University, Putian, China
Min Zhang

Department of Obstetrics and Gynecology, Putian University, Putian, China
Xianhui Min

Department of Obstetrics and Gynecology, Clinical Division, 900 Hospital of PLA Department of General Logistics, Fuzhou, China

Download PDF

Sections

Plain Text BibTeX RIS

APA Style

Dan Wu, Lixing Liu, Min Zhang, Xianhui Min. (2022). Genistein Improves Barrier Function and Proliferation of Human Umbilical Vein Endothelial Cells from Preeclampsia Patients. Clinical Medicine Research, 11(2), 28-35. https://doi.org/10.11648/j.cmr.20221102.13

Copy | Download

ACS Style

Dan Wu; Lixing Liu; Min Zhang; Xianhui Min. Genistein Improves Barrier Function and Proliferation of Human Umbilical Vein Endothelial Cells from Preeclampsia Patients. Clin. Med. Res. 2022, 11(2), 28-35. doi: 10.11648/j.cmr.20221102.13

Copy | Download

AMA Style

Dan Wu, Lixing Liu, Min Zhang, Xianhui Min. Genistein Improves Barrier Function and Proliferation of Human Umbilical Vein Endothelial Cells from Preeclampsia Patients. Clin Med Res. 2022;11(2):28-35. doi: 10.11648/j.cmr.20221102.13

Copy | Download

@article{10.11648/j.cmr.20221102.13,
  author = {Dan Wu and Lixing Liu and Min Zhang and Xianhui Min},
  title = {Genistein Improves Barrier Function and Proliferation of Human Umbilical Vein Endothelial Cells from Preeclampsia Patients},
  journal = {Clinical Medicine Research},
  volume = {11},
  number = {2},
  pages = {28-35},
  doi = {10.11648/j.cmr.20221102.13},
  url = {https://doi.org/10.11648/j.cmr.20221102.13},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.cmr.20221102.13},
  abstract = {Preeclampsia (PE), which is characterized by hypertension in women who have normal blood pressure before pregnancy and is accompanied by proteinuria, edema, and major organ damage, is the major cause of the increased mortality in pregnant women and perinatal fetuses. So far, genistein is recognized as the only safe and effective natural phytoestrogen without estrogen-like adverse reactions. Recent studies show that genistein may play a significant role in controlling oxidative/nitrative stress during preeclampsia, indicating a possible beneficial role of genistein in the prevention of preeclampsia. However, the ability of genistein to prevent and treat pregnancy-induced hypertension, especially preeclampsia, is unknown. To study the effect of genistein on endothelial cell damage in preeclampsia, we isolated human umbilical vein cells (HUVEC) from 20 normal pregnant women and 40 preeclampsia patients (half treated with genistein and the other half untreated). We found that HUVEC barrier function, proliferation, nitric oxide synthesis, glutathione peroxidase activity, and Bcl-2 expression were significantly decreased in the PE group. Furthermore, 8-hydroxy-2’-deoxyguanosine levels and Bax expression were significantly increased comparing to control group. Genistein treatment reversed these changes in the PE group, suggesting that genistein reduces endothelial cell damage in preeclampsia HUVEC and providing a supporting the use of genistein for PE prevention and treatment.},
 year = {2022}
}

Copy | Download

TY  - JOUR
T1  - Genistein Improves Barrier Function and Proliferation of Human Umbilical Vein Endothelial Cells from Preeclampsia Patients
AU  - Dan Wu
AU  - Lixing Liu
AU  - Min Zhang
AU  - Xianhui Min
Y1  - 2022/04/14
PY  - 2022
N1  - https://doi.org/10.11648/j.cmr.20221102.13
DO  - 10.11648/j.cmr.20221102.13
T2  - Clinical Medicine Research
JF  - Clinical Medicine Research
JO  - Clinical Medicine Research
SP  - 28
EP  - 35
PB  - Science Publishing Group
SN  - 2326-9057
UR  - https://doi.org/10.11648/j.cmr.20221102.13
AB  - Preeclampsia (PE), which is characterized by hypertension in women who have normal blood pressure before pregnancy and is accompanied by proteinuria, edema, and major organ damage, is the major cause of the increased mortality in pregnant women and perinatal fetuses. So far, genistein is recognized as the only safe and effective natural phytoestrogen without estrogen-like adverse reactions. Recent studies show that genistein may play a significant role in controlling oxidative/nitrative stress during preeclampsia, indicating a possible beneficial role of genistein in the prevention of preeclampsia. However, the ability of genistein to prevent and treat pregnancy-induced hypertension, especially preeclampsia, is unknown. To study the effect of genistein on endothelial cell damage in preeclampsia, we isolated human umbilical vein cells (HUVEC) from 20 normal pregnant women and 40 preeclampsia patients (half treated with genistein and the other half untreated). We found that HUVEC barrier function, proliferation, nitric oxide synthesis, glutathione peroxidase activity, and Bcl-2 expression were significantly decreased in the PE group. Furthermore, 8-hydroxy-2’-deoxyguanosine levels and Bax expression were significantly increased comparing to control group. Genistein treatment reversed these changes in the PE group, suggesting that genistein reduces endothelial cell damage in preeclampsia HUVEC and providing a supporting the use of genistein for PE prevention and treatment.
VL  - 11
IS  - 2
ER  -

Copy | Download